These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11463802)

  • 1. Intracavitary chemotherapy with 5-fluoro-2'-deoxyuridine (FdUrd) in malignant brain tumors.
    Nakagawa H; Maeda N; Tsuzuki T; Suzuki T; Hirayama A; Miyahara E; Wada K
    Jpn J Clin Oncol; 2001 Jun; 31(6):251-8. PubMed ID: 11463802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors.
    Yamada M; Nakagawa H; Fukushima M; Shimizu K; Hayakawa T; Ikenaka K
    J Neurooncol; 1998 Apr; 37(2):115-21. PubMed ID: 9524089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) in meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Oct; 26(10):873-9. PubMed ID: 9789291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Tsuzuki T; Hirayama A; Yamamoto H; Ikenaka K
    No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intrathecal administration of 5-fluoro-2'-deoxyuridine for the treatment of neoplastic meningitis.
    Nakagawa H; Miyahara E; Suzuki T; Wada K; Tamura M; Fukushima Y
    Neurosurgery; 2005 Aug; 57(2):266-80; discussion 266-80. PubMed ID: 16094155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
    Shimura T; Nakazawa S; Takahashi H; Node Y; Tamai J; Kumazaki T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):209-18. PubMed ID: 8311491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
    Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy.
    Naser-Hijazi B; Berger MR; Schmähl D; Schlag P; Hull WE
    J Cancer Res Clin Oncol; 1991; 117(4):295-304. PubMed ID: 1829730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol.
    Kawaguchi T; Fukushima S; Hayashi Y; Kaneko M; Nakano M
    Cancer Res; 1988 Aug; 48(15):4179-83. PubMed ID: 2839289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26.
    van Laar JA; Durrani FA; Rustum YM
    Cancer Res; 1993 Apr; 53(7):1560-4. PubMed ID: 8453623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
    Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
    Cancer Res; 1993 Jun; 53(12):2816-22. PubMed ID: 8504424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
    Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
    Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activities of pyrimidine nucleoside phosphorylase in brain tumors and antitumor effect of 5'-DFUR].
    Shibui S; Watanabe T; Miki Y; Nomura K; Miwa M
    No To Shinkei; 1983 Oct; 35(10):1017-22. PubMed ID: 6228241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.